应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
PHAT Phathom Pharmaceuticals
休市中 05-02 16:00:00 EDT
2.76
-0.60
-17.86%
盘后
2.80
+0.04
+1.45%
19:58 EDT
最高
3.40
最低
2.71
成交量
469.81万
今开
3.38
昨收
3.36
日振幅
20.39%
总市值
1.89亿
流通市值
1.53亿
总股本
6,838万
成交额
1,358万
换手率
8.45%
流通股本
5,561万
市净率
-0.56
ROE
-3489.00%
每股收益
-5.29
52周最高
19.71
52周最低
2.71
市盈率
-0.52
股息
0.00
股息收益率
0.00
ROA
-55.01%
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
高盛:维持Phathom Pharmaceuticals(PHAT.US)评级,由中性调整至中性评级, 目标价由10.00美元调整至5.00美元。
金融界 · 05-02 17:02
高盛:维持Phathom Pharmaceuticals(PHAT.US)评级,由中性调整至中性评级, 目标价由10.00美元调整至5.00美元。
Guggenheim:维持Phathom Pharmaceuticals(PHAT.US)评级,由买入调整至买入评级, 目标价由18.00美元调整至12.00美元。
金融界 · 05-02 16:33
Guggenheim:维持Phathom Pharmaceuticals(PHAT.US)评级,由买入调整至买入评级, 目标价由18.00美元调整至12.00美元。
Phathom Pharmaceuticals, Inc.盘中异动 大幅下跌5.32%报3.18美元
市场透视 · 05-02 13:44
Phathom Pharmaceuticals, Inc.盘中异动 大幅下跌5.32%报3.18美元
HC Wainwright & Co.:维持Phathom Pharmaceuticals(PHAT.US)评级,由买入调整至买入评级, 目标价由28.00美元调整至20.00美元。
金融界 · 05-02 12:41
HC Wainwright & Co.:维持Phathom Pharmaceuticals(PHAT.US)评级,由买入调整至买入评级, 目标价由28.00美元调整至20.00美元。
Phathom Pharmaceuticals, Inc.盘中异动 早盘股价大跌9.91%
市场透视 · 05-01 13:32
Phathom Pharmaceuticals, Inc.盘中异动 早盘股价大跌9.91%
Phathom Pharmaceuticals, Inc.盘中异动 股价大涨5.30%报4.37美元
市场透视 · 04-29
Phathom Pharmaceuticals, Inc.盘中异动 股价大涨5.30%报4.37美元
Phathom Pharmaceuticals, Inc.盘中异动 股价大涨5.83%
市场透视 · 04-15
Phathom Pharmaceuticals, Inc.盘中异动 股价大涨5.83%
Phathom Pharmaceuticals, Inc.盘中异动 股价大跌5.02%
市场透视 · 04-14
Phathom Pharmaceuticals, Inc.盘中异动 股价大跌5.02%
高盛:维持Phathom Pharmaceuticals(PHAT.US)评级,由中性调整至中性评级, 目标价由18.00美元调整至12.00美元。
金融界 · 03-10
高盛:维持Phathom Pharmaceuticals(PHAT.US)评级,由中性调整至中性评级, 目标价由18.00美元调整至12.00美元。
Phathom Pharmaceuticals, Inc.盘中异动 快速下跌5.24%报4.80美元
市场透视 · 03-10
Phathom Pharmaceuticals, Inc.盘中异动 快速下跌5.24%报4.80美元
Phathom Pharmaceuticals, Inc.2024财年实现净利润-3.34亿美元,同比减少65.35%
市场透视 · 03-09
Phathom Pharmaceuticals, Inc.2024财年实现净利润-3.34亿美元,同比减少65.35%
Phathom Pharmaceuticals(PHAT.US):2024年Q4财报实现营收2966.4万美元,前值为68.2万美元,预期值为2565万美元;每股收益为-0.79美元,前值为-0.80美元,预期值为-1.08美元。
金融界 · 03-06
Phathom Pharmaceuticals(PHAT.US):2024年Q4财报实现营收2966.4万美元,前值为68.2万美元,预期值为2565万美元;每股收益为-0.79美元,前值为-0.80美元,预期值为-1.08美元。
Phathom Pharmaceuticals第四季度调整后每股收益$(0.79)优于预期$(1.27),销售额$29.66百万优于$24.91百万预期
财报速递 · 03-06
Phathom Pharmaceuticals第四季度调整后每股收益$(0.79)优于预期$(1.27),销售额$29.66百万优于$24.91百万预期
Phathom Pharmaceuticals, Inc.盘中异动 股价大涨5.02%
市场透视 · 03-05
Phathom Pharmaceuticals, Inc.盘中异动 股价大涨5.02%
Phathom Pharmaceuticals, Inc.盘中异动 股价大涨5.37%报5.49美元
市场透视 · 03-04
Phathom Pharmaceuticals, Inc.盘中异动 股价大涨5.37%报5.49美元
Phathom Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.21%
市场透视 · 02-28
Phathom Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.21%
Phathom Pharmaceuticals, Inc.盘中异动 股价大涨5.38%报5.88美元
市场透视 · 02-26
Phathom Pharmaceuticals, Inc.盘中异动 股价大涨5.38%报5.88美元
Phathom Pharmaceuticals, Inc.盘中异动 快速拉升5.24%
市场透视 · 02-25
Phathom Pharmaceuticals, Inc.盘中异动 快速拉升5.24%
Phathom Pharmaceuticals, Inc.盘中异动 急速下跌5.03%报5.39美元
市场透视 · 02-24
Phathom Pharmaceuticals, Inc.盘中异动 急速下跌5.03%报5.39美元
Phathom Pharmaceuticals, Inc.盘中异动 股价大涨5.02%
市场透视 · 02-13
Phathom Pharmaceuticals, Inc.盘中异动 股价大涨5.02%
加载更多
公司概况
公司名称:
Phathom Pharmaceuticals
所属市场:
NASDAQ
上市日期:
2019-10-25
主营业务:
Phathom Pharmaceuticals, Inc.于2018年1月9日根据特拉华州法律注册成立。该公司是一家生物制药公司,专注于开发和商业化治疗胃肠道疾病或GI疾病的新疗法。
发行价格:
19.00
{"stockData":{"symbol":"PHAT","market":"US","secType":"STK","nameCN":"Phathom Pharmaceuticals","latestPrice":2.76,"timestamp":1746216000000,"preClose":3.36,"halted":0,"volume":4698063,"hourTrading":{"tag":"盘后","latestPrice":2.8,"preClose":2.76,"latestTime":"19:58 EDT","volume":62682,"amount":175166.7081,"timestamp":1746230332724},"delay":0,"floatShares":55607997,"shares":68377360,"eps":-5.29196,"marketStatus":"休市中","change":-0.6,"latestTime":"05-02 16:00:00 EDT","open":3.38,"high":3.395,"low":2.71,"amount":13581292.066164,"amplitude":0.203869,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-5.29196,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"listingDate":1571976000000,"exchange":"NASDAQ","adjPreClose":3.36,"preHourTrading":{"tag":"盘前","latestPrice":3.4,"preClose":3.36,"latestTime":"09:29 EDT","volume":3287,"amount":11090.5858398,"timestamp":1746192599151},"postHourTrading":{"tag":"盘后","latestPrice":2.8,"preClose":2.76,"latestTime":"19:58 EDT","volume":62682,"amount":175166.7081,"timestamp":1746230332724},"volumeRatio":2.5518576439377814,"optionData":{"bulkOrders":[{"symbol":"PHAT","call":false,"expireDate":1755230400000,"strike":"2.5","timestamp":1746204126870,"price":0.5,"volume":10000,"amount":500000,"type":"-"}]},"impliedVol":1.9488,"impliedVolPercentile":0.872},"requestUrl":"/m/hq/s/PHAT","defaultTab":"news","newsList":[{"id":"2532827973","title":"高盛:维持Phathom Pharmaceuticals(PHAT.US)评级,由中性调整至中性评级, 目标价由10.00美元调整至5.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532827973","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532827973?lang=zh_cn&edition=full","pubTime":"2025-05-03 01:02","pubTimestamp":1746205361,"startTime":"0","endTime":"0","summary":"高盛:维持Phathom Pharmaceuticals(PHAT.US)评级,由中性调整至中性评级, 目标价由10.00美元调整至5.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/03010250110395.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PHAT"],"gpt_icon":0},{"id":"2532822328","title":"Guggenheim:维持Phathom Pharmaceuticals(PHAT.US)评级,由买入调整至买入评级, 目标价由18.00美元调整至12.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532822328","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532822328?lang=zh_cn&edition=full","pubTime":"2025-05-03 00:33","pubTimestamp":1746203625,"startTime":"0","endTime":"0","summary":"Guggenheim:维持Phathom Pharmaceuticals(PHAT.US)评级,由买入调整至买入评级, 目标价由18.00美元调整至12.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/03003350110037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PHAT"],"gpt_icon":0},{"id":"2532825842","title":"Phathom Pharmaceuticals, Inc.盘中异动 大幅下跌5.32%报3.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532825842","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532825842?lang=zh_cn&edition=full","pubTime":"2025-05-02 21:44","pubTimestamp":1746193478,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日21时44分,Phathom Pharmaceuticals, Inc.股票出现波动,股价大幅跳水5.32%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.43%。Phathom Pharmaceuticals, Inc.公司简介:Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。该信息摘要如下:HC Wainwright & Co.:维持Phathom Pharmaceuticals评级,由买入调整至买入评级, 目标价由28.00美元调整至20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502214438aa2c81e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502214438aa2c81e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHAT"],"gpt_icon":0},{"id":"2532684572","title":"HC Wainwright & Co.:维持Phathom Pharmaceuticals(PHAT.US)评级,由买入调整至买入评级, 目标价由28.00美元调整至20.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532684572","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532684572?lang=zh_cn&edition=full","pubTime":"2025-05-02 20:41","pubTimestamp":1746189673,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.:维持Phathom Pharmaceuticals(PHAT.US)评级,由买入调整至买入评级, 目标价由28.00美元调整至20.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/02204150107370.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PHAT"],"gpt_icon":0},{"id":"2532003841","title":"Phathom Pharmaceuticals, Inc.盘中异动 早盘股价大跌9.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532003841","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532003841?lang=zh_cn&edition=full","pubTime":"2025-05-01 21:32","pubTimestamp":1746106357,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日21时32分,Phathom Pharmaceuticals, Inc.股票出现波动,股价急速跳水9.91%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.19%。其相关个股中,Transcode Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Kalaris Therapeutics, Inc.涨幅较大,Processa Pharmaceuticals, Inc.、Adial Pharmaceuticals, Inc、Transcode Therapeutics, Inc.较为活跃,换手率分别为28.83%、14.84%、11.62%,振幅较大的相关个股有Cyclacel Pharmaceuticals, Inc.、Transcode Therapeutics, Inc.、Metagenomi, Inc.,振幅分别为14.25%、12.32%、11.56%。Phathom Pharmaceuticals, Inc.公司简介:Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213237a6d011ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213237a6d011ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAT","BK4007"],"gpt_icon":0},{"id":"2531667827","title":"Phathom Pharmaceuticals, Inc.盘中异动 股价大涨5.30%报4.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531667827","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531667827?lang=zh_cn&edition=full","pubTime":"2025-04-30 00:39","pubTimestamp":1745944740,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日00时39分,Phathom Pharmaceuticals, Inc.股票出现波动,股价急速拉升5.30%。截至发稿,该股报4.37美元/股,成交量31.2406万股,换手率0.45%,振幅6.99%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.53%。其相关个股中,Cyclacel Pharmaceuticals, Inc.、Kala Bio, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大,Zyversa Therapeutics, Inc.、Onconetix, Inc.、Ibio, Inc.较为活跃,换手率分别为161.27%、151.07%、105.87%,振幅较大的相关个股有Cyclacel Pharmaceuticals, Inc.、Ibio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028,振幅分别为134.52%、54.29%、50.68%。Phathom Pharmaceuticals, Inc.公司简介:Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430003900a46c6d40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430003900a46c6d40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHAT"],"gpt_icon":0},{"id":"2527481594","title":"Phathom Pharmaceuticals, Inc.盘中异动 股价大涨5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527481594","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527481594?lang=zh_cn&edition=full","pubTime":"2025-04-15 21:54","pubTimestamp":1744725246,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日21时54分,Phathom Pharmaceuticals, Inc.股票出现异动,股价快速上涨5.83%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.01%。其相关个股中,Mural Oncology Plc、Prokidney Corp.、Verve Therapeutics, Inc.涨幅较大,Mural Oncology Plc、Metavia Inc.、Plus Therapeutics, Inc.较为活跃,换手率分别为620.67%、217.31%、87.06%,振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Mural Oncology Plc、Prokidney Corp.,振幅分别为80.08%、66.02%、43.24%。Phathom Pharmaceuticals, Inc.公司简介:Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504152154069738ab88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504152154069738ab88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAT","BK4007"],"gpt_icon":0},{"id":"2527110911","title":"Phathom Pharmaceuticals, Inc.盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527110911","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527110911?lang=zh_cn&edition=full","pubTime":"2025-04-15 03:00","pubTimestamp":1744657211,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日03时00分,Phathom Pharmaceuticals, Inc.股票出现波动,股价大幅跳水5.02%。截至发稿,该股报4.64美元/股,成交量42.9951万股,换手率0.62%,振幅7.99%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为2.70%。其相关个股中,Immatics N V C/Wts 01/07/2025 、Third Harmonic Bio, Inc.、天境生物涨幅较大,Processa Pharmaceuticals, Inc.、Artelo Biosciences, Inc.、Aditxt, Inc.较为活跃,换手率分别为805.00%、684.51%、342.76%,振幅较大的相关个股有Processa Pharmaceuticals, Inc.、Artelo Biosciences, Inc.、Zyversa Therapeutics, Inc.,振幅分别为78.58%、66.92%、66.29%。Phathom Pharmaceuticals, Inc.公司简介:Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415030011aa2c6f05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415030011aa2c6f05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHAT"],"gpt_icon":0},{"id":"2518205329","title":"高盛:维持Phathom Pharmaceuticals(PHAT.US)评级,由中性调整至中性评级, 目标价由18.00美元调整至12.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518205329","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518205329?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:41","pubTimestamp":1741628482,"startTime":"0","endTime":"0","summary":"高盛:维持Phathom Pharmaceuticals(PHAT.US)评级,由中性调整至中性评级, 目标价由18.00美元调整至12.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11014148641581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PHAT"],"gpt_icon":0},{"id":"2518227203","title":"Phathom Pharmaceuticals, Inc.盘中异动 快速下跌5.24%报4.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518227203","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518227203?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:33","pubTimestamp":1741613580,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时33分,Phathom Pharmaceuticals, Inc.股票出现异动,股价快速下挫5.24%。截至发稿,该股报4.80美元/股,成交量7.1426万股,换手率0.10%,振幅4.20%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.18%。其相关个股中,Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大,Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃,换手率分别为2045.40%、403.94%、59.60%,振幅较大的相关个股有Akero Therapeutics, Inc.、Xencor, Inc.、Seer, Inc.,振幅分别为99.91%、99.13%、98.72%。Phathom Pharmaceuticals, Inc.公司简介:Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213300abf2fcc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213300abf2fcc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHAT"],"gpt_icon":0},{"id":"2518289792","title":"Phathom Pharmaceuticals, Inc.2024财年实现净利润-3.34亿美元,同比减少65.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518289792","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518289792?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536072,"startTime":"0","endTime":"0","summary":"3月10日,Phathom Pharmaceuticals, Inc.公布财报,公告显示公司2024财年净利润为-3.34亿美元,同比减少65.35%;其中营业收入为55.25百万美元,同比增加8001.17%,每股基本收益为-5.29美元。机构评级:截至2025年3月10日,当前有8家机构对Phathom Pharmaceuticals, Inc.目标价做出预测,其中目标均价为21.62美元,其中最低目标价为12.00美元,最高目标价为28.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000218abf1755d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000218abf1755d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAT"],"gpt_icon":0},{"id":"2517152379","title":"Phathom Pharmaceuticals(PHAT.US):2024年Q4财报实现营收2966.4万美元,前值为68.2万美元,预期值为2565万美元;每股收益为-0.79美元,前值为-0.80美元,预期值为-1.08美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517152379","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517152379?lang=zh_cn&edition=full","pubTime":"2025-03-06 21:12","pubTimestamp":1741266750,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals(PHAT.US):2024年Q4财报实现营收2966.4万美元,前值为68.2万美元,预期值为2565万美元;每股收益为-0.79美元,前值为-0.80美元,预期值为-1.08美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/06211248574105.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PHAT"],"gpt_icon":0},{"id":"1118505333","title":"Phathom Pharmaceuticals第四季度调整后每股收益$(0.79)优于预期$(1.27),销售额$29.66百万优于$24.91百万预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1118505333","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118505333?lang=zh_cn&edition=full","pubTime":"2025-03-06 21:10","pubTimestamp":1741266636,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals报告本季度每股亏损$,超过分析师共识预期的$,提高了37.8%。这比去年同期每股亏损$增加了1.25%。这比去年同期销售额$682,000增长了4,250%。以上内容来自Benzinga Earnings专栏,原文如下:$Phathom Pharmaceuticals$ reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 37.8 percent. This is a 1.25 percent increase over losses of $ per share from the same period last year. The company reported quarterly sales of $29.66 million which beat the analyst consensus estimate of $24.91 million by 19.09 percent. This is a","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Phathom Pharmaceuticals第四季度调整后每股收益$(0.79)优于预期$(1.27),销售额$29.66百万优于$24.91百万预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHAT"],"gpt_icon":0},{"id":"2517284609","title":"Phathom Pharmaceuticals, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517284609","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517284609?lang=zh_cn&edition=full","pubTime":"2025-03-06 02:28","pubTimestamp":1741199304,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日02时28分,Phathom Pharmaceuticals, Inc.股票出现异动,股价大幅上涨5.02%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.37%。其相关个股中,Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大,Silexion Therapeutics Corp、Tc Biopharm Plc、Bioxcel Therapeutics, Inc.较为活跃,换手率分别为950.81%、305.93%、302.22%,振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Celularity Inc.,振幅分别为82.59%、54.27%、47.22%。Phathom Pharmaceuticals, Inc.公司简介:Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306022824a2610899&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306022824a2610899&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHAT"],"gpt_icon":0},{"id":"2517985659","title":"Phathom Pharmaceuticals, Inc.盘中异动 股价大涨5.37%报5.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517985659","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517985659?lang=zh_cn&edition=full","pubTime":"2025-03-05 04:15","pubTimestamp":1741119353,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日04时15分,Phathom Pharmaceuticals, Inc.股票出现波动,股价快速上涨5.37%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Rapport Therapeutics, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Hoth Therapeutics, Inc.涨幅较大,Aeon Biopharma, Inc.、Protagenic Therapeutics, Inc.、Windtree Therapeutics, Inc.较为活跃,换手率分别为1326.08%、1255.21%、1219.34%,振幅较大的相关个股有Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Plus Therapeutics, Inc.,振幅分别为122.48%、68.89%、68.09%。Phathom Pharmaceuticals, Inc.公司简介:Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305041553989bfb32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305041553989bfb32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHAT"],"gpt_icon":0},{"id":"2514937556","title":"Phathom Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514937556","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514937556?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:56","pubTimestamp":1740754592,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时56分,Phathom Pharmaceuticals, Inc.股票出现异动,股价急速跳水5.21%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.30%。其相关个股中,Enveric Biosciences, Inc.、Puma Biotechnology Inc、Bioxcel Therapeutics, Inc.涨幅较大,Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃,换手率分别为626.68%、367.39%、303.39%,振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Enveric Biosciences, Inc.,振幅分别为45.32%、35.13%、29.25%。Phathom Pharmaceuticals, Inc.公司简介:Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822563298968002&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822563298968002&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAT","BK4007"],"gpt_icon":0},{"id":"2514866851","title":"Phathom Pharmaceuticals, Inc.盘中异动 股价大涨5.38%报5.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514866851","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514866851?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:32","pubTimestamp":1740580331,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时32分,Phathom Pharmaceuticals, Inc.股票出现异动,股价急速上涨5.38%。截至发稿,该股报5.88美元/股,成交量5.9977万股,换手率0.09%,振幅2.06%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.20%。其相关个股中,Enveric Biosciences, Inc.、Nutriband Inc C/Wts 、Channel Therapeutics Corporation涨幅较大,Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.较为活跃,换手率分别为2798.65%、116.09%、90.30%,振幅较大的相关个股有Enveric Biosciences, Inc.、Channel Therapeutics Corporation、Cns Pharmaceuticals, Inc.,振幅分别为29.66%、16.86%、14.35%。Phathom Pharmaceuticals, Inc.公司简介:Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262232119893aae8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262232119893aae8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHAT"],"gpt_icon":0},{"id":"2514155390","title":"Phathom Pharmaceuticals, Inc.盘中异动 快速拉升5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514155390","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514155390?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:07","pubTimestamp":1740496063,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时07分,Phathom Pharmaceuticals, Inc.股票出现异动,股价大幅上涨5.24%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.95%。其相关个股中,Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大,Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃,换手率分别为1028.28%、777.69%、580.87%,振幅较大的相关个股有Organovo Holdings, Inc.、Gri Bio, Inc.、Adial Pharmaceuticals, Inc,振幅分别为121.95%、56.51%、47.10%。Phathom Pharmaceuticals, Inc.公司简介:Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230743962ffb03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230743962ffb03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAT","BK4007"],"gpt_icon":0},{"id":"2514703852","title":"Phathom Pharmaceuticals, Inc.盘中异动 急速下跌5.03%报5.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514703852","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514703852?lang=zh_cn&edition=full","pubTime":"2025-02-25 04:16","pubTimestamp":1740428178,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日04时16分,Phathom Pharmaceuticals, Inc.股票出现异动,股价大幅跳水5.03%。截至发稿,该股报5.39美元/股,成交量79.7323万股,换手率1.17%,振幅5.47%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.21%。其相关个股中,Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 涨幅较大,Pepgen Inc.、Aditxt, Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为326.72%、141.67%、40.73%,振幅较大的相关个股有Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 ,振幅分别为176.22%、162.04%、81.92%。Phathom Pharmaceuticals, Inc.公司简介:Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225041619962edcdd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225041619962edcdd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAT","BK4007"],"gpt_icon":0},{"id":"2511520426","title":"Phathom Pharmaceuticals, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511520426","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511520426?lang=zh_cn&edition=full","pubTime":"2025-02-14 00:49","pubTimestamp":1739465351,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日00时49分,Phathom Pharmaceuticals, Inc.股票出现异动,股价大幅上涨5.02%。截至发稿,该股报5.76美元/股,成交量12.9359万股,换手率0.19%,振幅6.02%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.90%。其相关个股中,Edesa Biotech, Inc.、Dominari Holdings Inc.、Enanta Pharmaceuticals, Inc.涨幅较大,Edesa Biotech, Inc.、Tc Biopharm Plc、Genprex, Inc.较为活跃,换手率分别为2828.37%、1194.06%、167.30%,振幅较大的相关个股有Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 、Tc Biopharm Plc C/Wts 10/02/2028 ,振幅分别为95.15%、92.30%、42.61%。Phathom Pharmaceuticals, Inc.公司简介:Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214004912a244c83b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214004912a244c83b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAT","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.phathompharma.com","stockEarnings":[{"period":"1week","weight":-0.3285},{"period":"1month","weight":-0.4973},{"period":"3month","weight":-0.5392},{"period":"6month","weight":-0.8489},{"period":"1year","weight":-0.7172},{"period":"ytd","weight":-0.6601}],"compareEarnings":[{"period":"1week","weight":0.0293},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0583},{"period":"6month","weight":-0.0075},{"period":"1year","weight":0.1222},{"period":"ytd","weight":-0.033}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Phathom Pharmaceuticals, Inc.于2018年1月9日根据特拉华州法律注册成立。该公司是一家生物制药公司,专注于开发和商业化治疗胃肠道疾病或GI疾病的新疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.063425},{"month":2,"riseRate":0.666667,"avgChangeRate":0.0903},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.119883},{"month":4,"riseRate":0.5,"avgChangeRate":0.053339},{"month":5,"riseRate":0.5,"avgChangeRate":-0.082197},{"month":6,"riseRate":0.6,"avgChangeRate":0.044836},{"month":7,"riseRate":0.8,"avgChangeRate":0.051978},{"month":8,"riseRate":0.6,"avgChangeRate":0.096985},{"month":9,"riseRate":0.4,"avgChangeRate":0.002397},{"month":10,"riseRate":0.2,"avgChangeRate":-0.078312},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.142586},{"month":12,"riseRate":0.666667,"avgChangeRate":0.072415}],"exchange":"NASDAQ","name":"Phathom Pharmaceuticals","nameEN":"Phathom Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Phathom Pharmaceuticals(PHAT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Phathom Pharmaceuticals(PHAT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Phathom Pharmaceuticals,PHAT,Phathom Pharmaceuticals股票,Phathom Pharmaceuticals股票老虎,Phathom Pharmaceuticals股票老虎国际,Phathom Pharmaceuticals行情,Phathom Pharmaceuticals股票行情,Phathom Pharmaceuticals股价,Phathom Pharmaceuticals股市,Phathom Pharmaceuticals股票价格,Phathom Pharmaceuticals股票交易,Phathom Pharmaceuticals股票购买,Phathom Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Phathom Pharmaceuticals(PHAT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Phathom Pharmaceuticals(PHAT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}